SCHEMBL7518032

SCHEMBL7518032

Nc1cnccc1C(=O)NC1CCCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ KDM6B O15054 1/20 0.51
▸ KDM4A O75164 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ KDM4D Q6B0I6 1/20 0.51
▸ KDM4C Q9H3R0 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ GAA P10253 3/20 0.50
▸ GLA P06280 1/20 0.50
▸ RAB9A P51151 4/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ HPGD P15428 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ EPHX1 P07099 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7515053 0.98 ALDH1A1 (0.50) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL7512985 0.97 ALDH1A1 (0.51) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL7510470 0.94 ALDH1A1 (0.54) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL7461632 0.84 KDM4E (0.50) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL7456523 0.82 NAMPT (0.50) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL15651270 0.81 SMYD3 (0.49) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL11735495 0.78 RAB9A (0.55) ALDH1A1KDM4EL3MBTL1KMT2ATDP1
SCHEMBL4455142 0.78 RAB9A (0.54) ALDH1A1KDM4EL3MBTL1MEN1KMT2A
SCHEMBL22720116 0.78 ALDH1A1 (0.66) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL21489703 0.77 SMYD3 (0.57) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 — — EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 — — US disclosed
US-8623866-B2 — — 2014-01-07 — — US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 — — EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A ALDH1A1 271/4885KDM4E 2322/4885L3MBTL1 3429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback